80 related articles for article (PubMed ID: 36305724)
1. ETS1 suppresses tumorigenicity of human colon cancer cells.
Suzuki H; Romano-Spica V; Papas TS; Bhat NK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4442-6. PubMed ID: 7753825
[TBL] [Abstract][Full Text] [Related]
2. An update on the roles of transcription factor Ets1 in autoimmune diseases.
Garrett-Sinha LA
WIREs Mech Dis; 2023; 15(6):e1627. PubMed ID: 37565573
[TBL] [Abstract][Full Text] [Related]
3. The role of the transcription factor Ets1 in carcinoma.
Dittmer J
Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
[TBL] [Abstract][Full Text] [Related]
4. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-mediated interaction between human E26 transcription factor 1 and specific protein 1 is required for tumor cell migration.
Wen X; Sun X; Ou Z; Jiang J; Chen Q; He X; Hu Z; Qiao H; Zhou K; Li X; Deng Y; Wen J
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1441-1452. PubMed ID: 36305724
[TBL] [Abstract][Full Text] [Related]
6. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
[TBL] [Abstract][Full Text] [Related]
7. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
8. ETS1 and SP1 drive DHX15 expression in acute lymphoblastic leukaemia.
Chen XL; Cai YH; Liu Q; Pan LL; Shi SL; Liu XL; Chen Y; Li JG; Wang J; Li Y; Li XF; Wang SY
J Cell Mol Med; 2018 May; 22(5):2612-2621. PubMed ID: 29512921
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter.
Dittmer J; Pise-Masison CA; Clemens KE; Choi KS; Brady JN
J Biol Chem; 1997 Feb; 272(8):4953-8. PubMed ID: 9030555
[TBL] [Abstract][Full Text] [Related]
10. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
11. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
Zhu D; Huang J; Liu N; Li W; Yan L
Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
Zhou H; Xiong Y; Zhang G; Liu Z; Li L; Hou S; Zhou T
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597491
[TBL] [Abstract][Full Text] [Related]
13. Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain.
Yu X; Liu H; Hamel KA; Morvan MG; Yu S; Leff J; Guan Z; Braz JM; Basbaum AI
Nat Commun; 2020 Jan; 11(1):264. PubMed ID: 31937758
[TBL] [Abstract][Full Text] [Related]
14. MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling.
Gu C; Cai J; Xu Z; Zhou S; Ye L; Yan Q; Zhang Y; Fang Y; Liu Y; Tu C; Wang X; He J; Li Q; Han L; Lin X; Li A; Liu S
Cell Death Dis; 2019 Sep; 10(10):739. PubMed ID: 31570702
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
